// App-Quantinova.ai

9545 : Porocarcinoma expression of high EGFR levels and sensitivity to EGFR or/and MEK inhibition.

Researchers

Presenter

  • Friedegund Elke Meier

Principal Investigators

  • Mildred Sergon

  • Marlene Garzarolli

  • Arno Ruetten

  • Sophia Blum

  • Michael Laniado

  • Selma Ugurel

  • Jan Maschke

  • Stefan Beissert

  • Dagmar Kulms

  • Dana Westphal

Medical Centers

  • Universitatsklinikum Carl Gustav Carus, Dresden, Germany

  • Dept. of Pathology, Carl Gustav Carus Medical Center, TU Dresden, Dresden, Germany

  • Dept. of Pathology, Carl Gustav Carus Medical Center, TU Dresden, Dresden, Germany

  • Institute of Dermatopathology, Friedrichshafen, Germany

  • Dept. of Pathology, Carl Gustav Carus Medical Center, TU Dresden, Dresden, Germany

  • University Hospital Carl Gustav Carus, Dresden, Germany

  • Department of Dermatology, University Hospital Erlangen and Department of Dermatology, University of Wurzburg, Essen, Germany

  • Dept. of Pathology, Carl Gustav Carus Medical Center, TU Dresden, Dresden, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Phospho-ERK

  • Phosphorylated-AKT

  • Epidermal growth factor receptor

  • Endothelial progenitor cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved